Background: The aim of this systematic review of literature is to know the characteristics of the patients with Covid-19 related mucormycosis, associated comorbidities as well as the use of steroids in people with Covid-19, the site of mucormycosis, the size and location of substance loss caused by surgical debridement, the contribution of maxillofacial rehabilitation in survivors. Methods: Using keywords, studies were selected from the following databases: MEDLINE (via PubMed), Science Direct and Google Scholar, including publications from 2019 until February 2022. They were filtered by title, abstract, and full text. Results: Among the 706 records identified from the databases, 28 publications were considered relevant and met the eligibility criteria, including 21 case reports and 7 case series. These studies included 69 patients with a mean age of 50.4 years, from different countries. Conclusions: Despite the the limitations of our review, we can conclude that mucormycosis is an opportunistic and deadly fungal illness in uncontrolled diabetes individuals who are immunocompromised. Physicians should be conscious of red flags such as previous Covid-19 infection, particularly in those who were hospitalized and given high-flow oxygen therapy as well as high-dose long-term steroids; metabolic diseases.
Cite this paper
Zeroual, R. and Alansari, I. (2023). Covid-19 Associated Mucormycosis and Its Surgical Sequelae: A Systematic Review of the Literature. Open Access Library Journal, 10, e9866. doi: http://dx.doi.org/10.4236/oalib.1109866.
World Health Organization (2022) Weekly Epidemiological Update on COVID-19— 15 March 2022. Emergency Situational Updates.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Abdoli, A., Falahi, S. and Kenarkoohi, A. (2021) COVID-19-Associated Opportunistic Infections: A Snapshot on the Current Reports. Clinical and Experimental Medicine, 22, 327-346. https://doi.org/10.1007/s10238-021-00751-7
Bhattacharyya, A., Sarma, P., Sharma, D.J., Das, K.K., Kaur, H., Prajapat, M., et al. (2021) Rhino-Orbital-Cerebral-Mucormycosis in COVID-19: A Systematic Review. Indian Journal of Pharmacology, 53, 317-327.
Baker, R.D. (1957) Mucormycosis—A New Disease? Journal of the American Medical Association, 163, 805-808. https://doi.org/10.1001/jama.1957.02970450007003
Jeong, W., Keighley, C., Wolfe, R., Lee, W.L., Slavin, M.A., Kong, D.C.M., et al. (2019) The Epidemiology and Clinical Manifestations of Mucormycosis: A Systematic Review and Meta-Analysis of Case Reports. Clinical Microbiology and Infection, 25, 26-34. https://doi.org/10.1016/j.cmi.2018.07.011
Nagalli, S. and Kikkeri, N.S. (2021) Mucormycosis in COVID-19: A Systematic Review of Literature. Infezioni in Medicina, 29, 504-512.
https://doi.org/10.53854/liim-2904-2
Prakash, H., Ghosh, A.K., Rudramurthy, S.M., Singh, P., Xess, I., Savio, J., et al. (2019) A Prospective Multicenter Study on Mucormycosis in India: Epidemiology, Diagnosis, and Treatment. Medical Mycology, 57, 395-402.
https://doi.org/10.1093/mmy/myy060
Sarfraz, Z., Sarfraz, A., Jaiswal, V., Poudel, S., Bano, S., Hanif, M., Singh Shrestha, P., Sarfraz, M., Michel, G. and Cherrez-Ojeda, I. (2022) The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review. Journal of Primary Care & Community Health, 13, 1-8.
Skiada, A., Pavleas, I. and Drogari-Apiranthitou, M. (2020) Epidemiology and Diagnosis of Mucormycosis: An Update. Journal of Fungi (Basel), 6, Article No. 265.
https://doi.org/10.3390/jof6040265
Bayram, N., Ozsaygili, C., Sav, H., Tekin, Y., Gundogan, M., Pangal, E., et al. (2021) Susceptibility of Severe COVID-19 Patients to Rhino-Orbital Mucormycosis Fungal Infection in Different Clinical Manifestations. Japanese Journal of Ophthalmology, 65, 515-525. https://doi.org/10.1007/s10384-021-00845-5
Mohammadi, F., Badri, M., Safari, S. and Hemmat, N. (2021) A Case Report of Rhino-Facial Mucormycosis in a Non-Diabetic Patient with COVID-19: A Systematic Review of Literature and Current Update. BMC Infectious Diseases, 21, Article No. 906. https://doi.org/10.1186/s12879-021-06625-3
Deek, A.J., Boukovalas, S., Rathfoot, C.J. and Gotcher, J.E. (2022) Rhinocerebral Mucormycosis as a Sequelae of COVID-19 Treatment: A Case Report & Literature Review. Journal of Oral and Maxillofacial Surgery, 80, 333-340.
https://doi.org/10.1016/j.joms.2021.09.009
Werthman-Ehrenreich, A. (2021) Mucormycosis with Orbital Compartment Syndrome in a Patient with COVID-19. The American Journal of Emergency Medicine, 42, e5-264. e8. https://doi.org/10.1016/j.ajem.2020.09.032
Chowdhury, M., Takata, J., Beegun, I., Burd, C., Tatla, T. and Corrah, T. (2022) Image Challenge: A Diabetic Man with Facial Swelling following Recent COVID-19 Infection. Clinical Infection in Practice, 13, Article ID: 100129.
https://doi.org/10.1016/j.clinpr.2021.100129
Maini, A., Tomar, G., Khanna, D., Kini, Y., Mehta, H. and Bhagyasree, V. (2021) Sino-Orbital Mucormycosis in a COVID-19 Patient: A Case Report. International Journal of Surgery Case Reports, 82, Article ID: 105957.
https://doi.org/10.1016/j.ijscr.2021.105957
Saad, R.H. and Mobarak, F.A. (2021) The Diversity and Outcome of Post-COVID Mucormycosis: A Case Report. International Journal of Surgery Case Reports, 88, Article ID: 106522. https://doi.org/10.1016/j.ijscr.2021.106522
Raghu, D.R., Daswaney, D.A. and Gopinathan, D.V. (2021) Mucormycosis as a Complication of COVID-19—A Case Report. Visual Journal of Emergency Medicine, 25, Article ID: 101150. https://doi.org/10.1016/j.visj.2021.101150
Chauhan, K, Soni, D., Sarkar, D., Karuna, T., Sharma, B., Singh, S., et al. (2021) Mucormycosis after COVID-19 in a Patient with Diabetes. The Lancet, 398, E10.
https://doi.org/10.1016/S0140-6736(21)01641-X
Baskar, H.C., Chandran, A., Reddy, C.S. and Singh, S. (2021) Rhino-Orbital Mucormycosis in a COVID-19 Patient. BMJ Case Reports, 14, e244232.
https://doi.org/10.1136/bcr-2021-244232
Tabarsi, P., Khalili, N., Pourabdollah, M., Sharifynia, S., Naeini, A.S., Ghorbani, J., et al. (2021) Case Report: COVID-19-Associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring after Treatment with Corticosteroids. The American Journal of Tropical Medicine and Hygiene, 105, 449-453. https://doi.org/10.4269/ajtmh.21-0359
Shakir, M., Maan, M.H.A. and Waheed, S. (2021) Mucormycosis in a Patient with COVID-19 with Uncontrolled Diabetes. BMJ Case Reports, 14, e245343.
https://doi.org/10.1136/bcr-2021-245343
Ostovan, V.R., Rezapanah, S., Behzadi, Z., Hosseini, L., Jahangiri, R., Anbardar, M.H., et al. (2021) Coronavirus Disease (COVID-19) Complicated by Rhino-Orbital-Cerebral Mucormycosis Presenting with Neurovascular Thrombosis: A Case Report and Review of Literature. Journal of NeuroVirology, 27, 644-649.
https://doi.org/10.1007/s13365-021-00996-8
Dilek, A., Ozaras, R., Ozkaya, S., Sunbul, M., Sen, E.I. and Leblebicioglu, H. (2021) COVID-19-Associated Mucormycosis: Case Report and Systematic Review. Travel Medicine and Infectious Disease, 44, Article ID: 102148.
https://doi.org/10.1016/j.tmaid.2021.102148
Venugopal, A. and Marya, A. (2021) Palatal Mucormycosis in a Patient with SARS-CoV-2 Infection. Canadian Medical Association Journal, 193, E1254.
https://doi.org/10.1503/cmaj.211026
Ingle, Y., Sarode, S.C., Sarode, G., Ingle, M. and Ingle, S. (2022) Concurrent Plexiform Ameloblastoma and COVID-19-Associated Mucormycosis of the Maxilla. Oral Oncology, 125, Article ID: 105712.
https://doi.org/10.1016/j.oraloncology.2022.105712
Nori, W. and Norri, S. (2021) Mucormycosis in COVID-19 Diabetic Patient: A Review and Case Report. Proceedings of the 1st International Ninevah Conference on Medical Sciences (INCMS 2021), Mosul, 5-7 September 2021, 1-4.
https://doi.org/10.2991/ahsr.k.211012.001
Torabiyan, S., Dalfardi, B. and Sanjari, M. (2021) Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature. Case Reports in Endocrinology, 2021, Article ID: 2765867.
https://doi.org/10.1155/2021/2765867
Nehara, H.R., Puri, I., Singhal, V., Ih, S., Bishnoi, B.R. and Sirohi, P. (2021) Rhinocerebral Mucormycosis in COVID-19 Patient with Diabetes a Deadly Trio: Case Series from the North-Western Part of India. Indian Journal of Medical Microbiology, 39, 380-383. https://doi.org/10.1016/j.ijmmb.2021.05.009
Diwakar, J., Samaddar, A., Konar, S.K., Bhat, M.D., Manuel, E., Hb, V., et al. (2021) First Report of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis in Pediatric Patients with Type 1 Diabetes Mellitus. Journal of Medical Mycology, 31, Article ID: 101203. https://doi.org/10.1016/j.mycmed.2021.101203
Arana, C., Ramírez, R.E.C., Xipell, M., Casals, J., Moreno, A., Herrera, S., et al. (2021) Mucormycosis Associated with COVID-19 in Two Kidney Transplant Patients. Transplant Infectious Disease, 23, e13652. https://doi.org/10.1111/tid.13652
Dabas, A., Swarnim, S., Sagar, T. and Mantan, M. (2021) Mucormycosis with Severe Acute Respiratory Syndrome Coronavirus-2 Patients on Hemodialysis: A Case Series with Review of Literature. Saudi Journal of Kidney Diseases and Transplantation, 2, 1152-1157.
Aggarwal, S.K., Kaur, U., Talda, D., Pandey, A., Jaiswal, S., Kanakan, A., et al. (2021) Case Report: Rhino-Orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors. The American Journal of Tropical Medicine and Hygiene, 106, 566-570. https://doi.org/10.4269/ajtmh.21-0777
Ashour, M.M., Abdelaziz, T.T., Ashour, D.M., Askoura, A., Saleh, M.I. and Mahmoud, M.S. (2021) Imaging Spectrum of Acute Invasive Fungal Rhino-Orbital-Cerebral Sinusitis in COVID-19 Patients: A Case Series and a Review of Literature. Journal of Neuroradiology, 48, 19-24.
https://doi.org/10.1016/j.neurad.2021.05.007
Paul, S.S., Kumar, R., Meena, V.P., Ramprasad, A., Garg, P., Keri, V.C., et al. (2021) Clinical Characteristics and Outcomes of 16 Cases with COVID-19 and Mucormycosis: Experience from a Tertiary Care Center in India and Review of Literature.
https://doi.org/10.21203/rs.3.rs-533347/v1
Monika, P. and Chandraprabha, M.N. (2022) Risks of Mucormycosis in the Current COVID-19 Pandemic: A Clinical Challenge in Both Immunocompromised and Immunocompetent Patients. Molecular Biology Reports, 49, 4977-4988.
https://doi.org/10.1007/s11033-022-07160-3
Pushparaj, K., Bhotla, H.K., Arumugam, V.A., Pappusamy, M., Easwaran, M., Liu, W.C., et al. (2022) Mucormycosis (Black Fungus) Ensuing COVID-19 and Comorbidity Meets—Magnifying Global Pandemic Grieve and Catastrophe Begins. Science of the Total Environment, 805, Article ID: 150355.
https://doi.org/10.1016/j.scitotenv.2021.150355
Janjua, O.S., Shaikh, M.S., Fareed, M.A., Qureshi, S.M., Khan, M.I., Hashem, D., et al. (2021) Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes. Journal of Fungi (Basel), 8, Article No. 44. https://doi.org/10.3390/jof8010044
Soni, S., Pudake, R.N., Jain, U. and Chauhan, N.A. (2022) Systematic Review on SARS-CoV-2-Associated Fungal Coinfections. Journal of Medical Virology, 94, 99-109. https://doi.org/10.1002/jmv.27358
Spellberg, B., Edwards, J. and Ibrahim, A. (2005) Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management. Clinical Microbiology Reviews, 18, 556-569. https://doi.org/10.1128/CMR.18.3.556-569.2005
Singh, A.K., Singh, R., Joshi, S.R. and Misra, A. (2021) Mucormycosis in COVID-19: A Systematic Review of Cases Reported Worldwide and in India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15, Article ID: 102146.
https://doi.org/10.1016/j.dsx.2021.05.019
Azhar, A., Khan, W.H., Khan, P.A., Alhosaini, K., Owais, M. and Ahmad. A. (2022) Mucormycosis and COVID-19 Pandemic: Clinical and Diagnostic Approach. Journal of Infection and Public Health, 15, 466-479.
https://doi.org/10.1016/j.jiph.2022.02.007
SeyedAlinaghi, S., Karimi, A., Barzegary, A., Pashaei, Z., Afsahi, A.M., Alilou, S., et al. (2022) Mucormycosis Infection in Patients with COVID-19: A Systematic Review. Health Science Reports, 5, e529. https://doi.org/10.1002/hsr2.529
Hoenigl, M., Seidel, D., Carvalho, A., Rudramurthy, S.M., Arastehfar, A., Gangneux, J.P., et al. (2022) The Emergence of COVID-19 Associated Mucormycosis: A Review of Cases from 18 Countries. The Lancet Microbe, 3, E543-E552.
https://doi.org/10.1016/S2666-5247(21)00237-8
Sengupta, I. and Nayak, T. (2022) Coincidence or Reality behind Mucormycosis, Diabetes Mellitus and COVID-19 Association: A Systematic Review. Journal of Medical Mycology, 32, Article ID: 101257.
https://doi.org/10.1016/j.mycmed.2022.101257
Lionakis, M.S. and Kontoyiannis, D.P. (2003) Glucocorticoids and Invasive Fungal Infections. The Lancet, 362, 1828-1838.
https://doi.org/10.1016/S0140-6736(03)14904-5
Ramamoorthy, S. and Cidlowski, J.A. (2016) Corticosteroids: Mechanisms of Action in Health and Disease. Rheumatic Disease Clinics of North America, 42, 15-31.
John, T.M., Jacob, C.N. and Kontoyiannis, D.P. (2021) When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. Journal of Fungi (Basel), 7, Article 298. https://doi.org/10.3390/jof7040298
Hussain, S., Baxi, H., Riad, A., Klugarová, J., Pokorná, A., Slezáková, S., et al. (2021) COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping. International Journal of Environmental Research and Public Health, 18, Article 10340.
https://doi.org/10.3390/ijerph181910340
Tan, S.W., Tam, Y.C. and Oh, C.C. (2021) Skin Manifestations of COVID-19: A Worldwide Review. JAAD International, 2, 119-133.
https://doi.org/10.1016/j.jdin.2020.12.003
Castrejón-Pérez, A.D., Welsh, E.C., Miranda, I., Ocampo-Candiani, J. and Welsh, O. (2017) Cutaneous Mucormycosis. Anais Brasileiros de Dermatologia, 92, 304-311.
https://doi.org/10.1590/abd1806-4841.20176614
Wali, U., Balkhair, A. and Al-Mujaini, A. (2021) Cerebro-Rhino Orbital Mucormycosis: An Update. Journal of Infection and Public Health, 5, 116-126.
https://doi.org/10.1016/j.jiph.2012.01.003
Aribandi, M., McCoy, V.A. and Bazan, C. (2007) Imaging Features of Invasive and Noninvasive Fungal Sinusitis: A Review. RadioGraphics, 27, 1283-1296.
https://doi.org/10.1148/rg.275065189
Alastruey-Izquierdo, A., Castelli, M.V., Cuesta, I., Monzon, A., Cuenca-Estrella, M. and Rodriguez-Tudela, J.L. (2009) Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers. Antimicrobial Agents and Chemotherapy, 53, 1686-1689.
https://doi.org/10.1128/AAC.01467-08
Skiada, A., Lass-Floerl, C., Klimko, N., Ibrahim, A., Roilides, E. and Petrikkos, G. (2018) Challenges in the Diagnosisand Treatment of Mucormycosis. Medical Mycology, 56, 93-101. https://doi.org/10.1093/mmy/myx101
Spellberg, B. and Ibrahim, A.S. (2010) Recent Advances in the Treatment of Mucormycosis. Current Infectious Disease Reports, 12, 423-429.
https://doi.org/10.1007/s11908-010-0129-9
Ballester, F., Pastor, F.J. and Guarro, J. (2008) In vitro Activities of Combinations of Amphotericin B, Posaconazole and Four Other Agents against Rhizopus. Journal of Antimicrobial Chemotherapy, 61, 755-757. https://doi.org/10.1093/jac/dkn005
Singh, A., Ahmad, N., Varadarajan, A., Vikram, N., Singh, T.P., Sharma, S., et al. (2021) Lactoferrin, a Potential Iron-Chelator as an Adjunct Treatment for Mucormycosis—A Comprehensive Review. International Journal of Biological Macromolecules, 187, 988-998. https://doi.org/10.1016/j.ijbiomac.2021.07.156
Scott, C., Arora, G., Dickson, K. and Lehmann, C. (2021) Iron Chelation in Local Infection. Molecules, 26, Article 189. https://doi.org/10.3390/molecules26010189
Palacios, J.J., Hanson, E.V., Rendon, M.A.M. and Infante, R.S.L. (2019) Reconstruction of Head and Neck Mucormycosis: A Literature Review and Own Experience in Immediate Reconstruction. Journal of Reconstructive Microsurgery Open, 4, e65-e72. https://doi.org/10.1055/s-0039-1695713
Kumar, P.R., Kalavathy, N., Shetty, M.M., Sanketh, A.K., Venkataramani, A. and Sv, R. (2021) Prosthodontic Perspectives in Mucormycosis: A Review. Journal of Dental Sciences, 13, 293-302. https://doi.org/10.26715/rjds.13_4_4
Gupta, A.D., Verma, A., Islam, J.I., Agarwal, S. (2016) Maxillofacial Defects and Their Classification: A Review. International Journal of Advanced Research, 4, 109-114. https://doi.org/10.21474/IJAR01/618
Fadhil, S.M.T. and Mumcu, E. (2019) Rehabilitation of a Patient with Palatal Defect—A Case Report. Journal of Surgery and Surgical Research, 5, 93-96.
https://doi.org/10.17352/2455-2968.000081
Schneider, R. (2012) Maxillofacial Rehabilitation: Prosthodontic and Surgical Management of Cancer-Related, Acquired, and Congenital Defects of the Head and Neck. Special Care in Dentistry, 32, 125.
https://doi.org/10.1111/j.1754-4505.2012.00253.x
Mani, U.M., Mohamed, K., Kumar, A.K. and Inbarajan, A. (2019) A Modified Technique to Fabricate a Complete Hollow Obturator for Bilateral Maxillectomy in a Patient with Mucormycosis—A Technical Case Report. Special Care in Dentistry, 39, 610-616. https://doi.org/10.1111/scd.12423
Buurman, D.J.M., Speksnijder, C., Engelen, B.H.B.T. and Kessler, P. (2020) Masticatory Performance and Oral Health-Related Quality of Life in Edentulous Maxillectomy Patients: A Cross-Sectional Study to Compare Implant-Supported Obturators and Conventional Obturators. Clinical Oral Implants Research, 31, 405-416.
https://doi.org/10.1111/clr.13577
